IRAQ BW FACILITIES

File: 070296_cia_74100_74100_01.txt
Page: 01
Total Pages: 1
Subject: IRAQ BW FACILITIES

Not Finally Evaluated Intelligence







TO FACILITATE ELECTRONIC ACCESS, THIS DOCUMENT HAS BEEN

REFORMATTED TO ELIMINATE INFORMATION THAT DOES NOT PERTAIN

TO GULF WAR ILLNESS ISSUES OR THAT IS CLASSIFIED. A COPY OF

THIS REDACTED DOCUMENT, IN ORIGINAL FORMAT, IS AVAILABLE ON

REQUEST.







IRAQ CRITICAL NODE BW FACILITIES







THERE ARE A NUMBER OF FACILITIES ASSOCIATED WITH THE

IRAQI BIOLOGICAL WARFARE (BW) PROGRAM. THESE FACILITIES CAN

BE SPLIT INTO TWO BROAD CATEGORIES; PRODUCTION AND STORAGE.

BECAUSE THERE ARE A NUMBER OF FACILITIES, NO ONE CAN BE

CONSIDERED "THE" CRITICAL NODE.



PRODUCTION FACILITIES



THE FOLLOWING ARE PRODUCTION LOCATIONS AFFILIATED WITH

THE BW PROGRAM.







SALMAN PAK

ABU GHRAIB VACCINE PLANT

TAJI PILOT PLANT







SALMAN PAK HAS A HIGH CONTAINMENT BUILDING THAT IS

PROBABLY USED FOR RESEARCH, DEVELOPMENT, AND PRODUCTION OF

BW AGENTS







THE ABU GHRAIB VACCINE PLANT IS THE SITE OF BOTULINUM

TOXIN PRODUCTION.







TAJI IS THE LOCATION OF A PILOT-SCALE PRODUCTION

FACILITY,







THIS PLANT IS FOR PRODUCTION OF ANTHRAX.







THE PLANT HAS BEEN OPERATIONAL

FOR SEVERAL YEARS. A FACILITY THAT MAY BE THIS PILOT PLANT

HAS BEEN IDENTIFIED IN THE TAJI AREA.



SUSPECT PRODUCTION LOCATIONS



THE INFANT FORMULA PLANT AT ABU GHRAIB MAY BE INVOLVED

IN THE PRODUCTION OF BW AGENTS.







PRODUCING LARGE QUANTITIES

OF EITHER ANTHRAX OR BOTULINUM.



THE TUWAITHA NUCLEAR RESEARCH CENTER MAY HAVE SOME ROLE

IN THE BW PROGRAM.







IRAQ'S MAIN PHARMACEUTICAL PLANT, SAMARRA DRUG

INDUSTRIES (SDI), PRODUCES-NUMEROUS BIOLOGICAL PRODUCTS AND

WAS BUILT IN THE 1970s          ALTHOUGH THE PLANT

APPEARS TO BE LEGITIMATE AND DOES PRODUCE ANTIBIOTICS, THE

EQUIPMENT THERE WOULD ALLOW THE IRAQIS TO PRODUCE A VARIETY

OF BW AGENTS.







1.5(c)

74100:74100